Identification of methylated genes associated with aggressive clinicopathological features in Mantle cell lymphoma

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Enjuanes, Anna ^a   Fernàndez, Verònica ^a   Hernández, Luis ^a   Navarro, Alba ^a   Beà, Sílvia ^a   Pinyol, Magda ^a   López Guillermo, Armando ^a   Rosenwald, Andreas ^b   Ott, German ^c   Campo, Elías ^a   Jares, Pedro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

AHR GENE; ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SILENCING; HOXA9 GENE; HUMAN; HUMAN CELL; MANTLE CELL LYMPHOMA; NPTX2 GENE; NR2F2 GENE; PHENOTYPE; QUANTITATIVE ANALYSIS; ROBO1 GENE; SOX9 GENE; DISEASE COURSE; EPIGENETICS; GENETICS; MORTALITY; PATHOLOGY; SURVIVAL RATE; TUMOR CELL LINE; TUMOR GENE;

B-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; DNA METHYLATION; EPIGENOMICS; GENE EXPRESSION PROFILING; GENES, NEOPLASM; HUMANS; LYMPHOMA, MANTLE-CELL; SURVIVAL RATE;

EID: 79956125740     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019736     Document Type: Article

References (39)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. Fourth Edition Lyon IARC press.
2. Jares P, Colomer D, Campo E, (2007) Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7: 750-762.
3. Egger G, Liang G, Aparicio A, Jones PA, (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
4. Esteller M, (2008) Epigenetics in cancer. N Engl J Med 358: 1148-1159.
5. Gronbaek K, Ralfkiaer U, Dahl C, Hother C, Burns JS, et al. (2008) Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms. Mod Pathol 21: 632-638.
6. Koyama M, Oka T, Ouchida M, Nakatani Y, Nishiuchi R, et al. (2003) Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation. Lab Invest 83: 1849-1858.
7. Leshchenko VV, Kuo PY, Shaknovich R, Yang DT, Gellen T, et al. (2010) Genome wide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 116: 1025-1034.
8. Esteller M, (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
9. Ansorge WJ, (2009) Next-generation DNA sequencing techniques. N Biotechnol 25: 195-203.
10. Karpf AR, Jones DA, (2002) Reactivating the expression of methylation silenced genes in human cancer. Oncogene 21: 5496-5503.
11. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB, (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107.
12. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van EM, et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149.
13. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, et al. (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63: 3735-3742.
14. Pruitt KD, Harrow J, Harte RA, Wallin C, Diekhans M, et al. (2009) The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. Genome Res 19: 1316-1323.
15. Rahmatpanah FB, Carstens S, Guo J, Sjahputera O, Taylor KH, et al. (2006) Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior. Leukemia 20: 1855-1862.
16. Taylor KH, Kramer RS, Davis JW, Guo J, Duff DJ, et al. (2007) Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 67: 8511-8518.
17. Muthusamy V, Duraisamy S, Bradbury CM, Hobbs C, Curley DP, et al. (2006) Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res 66: 11187-11193.
18. Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey J, et al. (2006) Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res 66: 6665-6674.
19. Ripperger T, von NN, Kamphues K, Emura M, Lehmann U, et al. (2007) Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas. Haematologica 92: 460-468.
20. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ, (2005) Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5: 615-625.
21. Claus R, Almstedt M, Lubbert M, (2007) Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol 32: 511-520.
22. Ueki T, Walter KM, Skinner H, Jaffee E, Hruban RH, et al. (2002) Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived. Oncogene 21: 2114-2117.
23. Khulan B, Thompson RF, Ye K, Fazzari MJ, Suzuki M, et al. (2008) Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 16: 1046-55.
24. Aleman A, Adrien L, Lopez-Serra L, Cordon-Cardo C, Esteller M, et al. (2008) Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. Br J Cancer 98: 466-473.
25. Bennett LB, Schnabel JL, Kelchen JM, Taylor KH, Guo J, et al. (2009) DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma. Genes Chromosomes Cancer 48: 828-841.
26. Afonja O, Raaka BM, Huang A, Das S, Zhao X, et al. (2002) RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene 21: 7850-7860.
27. Drivdahl R, Haugk KH, Sprenger CC, Nelson PS, Tennant MK, et al. (2004) Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Oncogene 23: 4584-4593.
28. Mulero-Navarro S, Carvajal-Gonzalez JM, Herranz M, Ballestar E, Fraga MF, et al. (2007) The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. Carcinogenesis 27: 1099-1104.
29. Wu Q, Lothe RA, Ahlquist T, Silins I, Trope CG, et al. (2007) DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer 6: 45.
30. Rauch T, Wang Z, Zhang X, Zhong X, Wu X, et al. (2007) Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A 104: 5527-5532.
31. Bullinger L, Ehrich M, Dohner K, Schlenk RF, Dohner H, et al. (2010) Quantitative DNA-methylation predicts survival in adult acute myeloid leukemia. Blood 115: 636-642.
32. Xian J, Aitchison A, Bobrow L, Corbett G, Pannell R, et al. (2004) Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter. Cancer Res 64: 6432-6437.
33. Dallol A, Forgacs E, Martinez A, Sekido Y, Walker R, et al. (2002) Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers. Oncogene 21: 3020-3028.
34. Sundaresan V, Chung G, Heppell-Parton A, Xiong J, Grundy C, et al. (1998) Homozygous deletions at 3p12 in breast and lung cancer. Oncogene 17: 1723-1729.
35. Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP, (2009) Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer. Breast Cancer Res 11: R14.
36. Issa JP, (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993.
37. Salaverria I, Perez-Galan P, Colomer D, Campo E, (2006) Mantle cell lymphoma: from pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 91: 11-16.
38. Pinyol M, Salaverria I, Bea S, Fernandez V, Colomo L, et al. (2006) Unbalanced expression of licensing DNA replication factors occurs in a subset of mantle cell lymphomas with genomic instability. Int J Cancer 119: 2768-2774.
39. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, et al. (2005) Galaxy: a platform for interactive large-scale genome analysis. Genome Res 15: 1451-1455.